Is Danaher Corp (DHR) a Smart Long-term Buy?

Del Principe O’Brien Financial Advisors recently released its third-quarter investor letter – a copy of which is available for download here. The fund posted a return of 8.6% for the quarter, underperforming its benchmark, the S&P 500 Index which returned 8.9% in the same quarter. You should check out Del Principe O’Brien Financial Advisors top 5 stock picks for investors to buy right now, which could be the biggest winners of 2021.

In the Q3 2020 Investor Letter, Del Principe O’Brien Financial Advisors highlighted a few stocks and Danaher Corp (NYSE:DHR) is one of them. Danaher Corp (NYSE:DHR) designs, manufactures and markets professional, medical, industrial and commercial products and services. Year-to-date, Danaher Corp (NYSE:DHR) stock gained 46.3% and on December 17th it had a closing price of $224.49. Here is what Del Principe O’Brien Financial Advisors said:

“Danaher, which designs, manufactures, and markets life science, diagnostics, dental, environmental, and applied solutions, is a prime example of how to use the business strategy of “bolt-on” acquisitions. Led by capital allocation experts the Rales brothers, Danaher will purchase a company in a fragmented industry, create a strategic platform for providing a unique service, and then spin off the company when it can create even more value as an independent entity.

Since Danaher’s bolt-on acquisition of the biopharma business of General Electric’s Life Sciences division for $21.4 billion in March 2019, we have realized a gain of well over 100%. The move boosted Danaher’s stock from around $90 (our purchase price) to the $210s. A gain like this is one of the big upsides of investing in a serial acquirer.”

Sergey Nivens/Shutterstock.com

In September, we published an article revealing Del Principe O’Brien Financial Advisors bullish investment thesis on Danaher Corp (NYSE:DHR) stock in its Q2 2019 investor letter. This suggests that the investment firm has been bullish for a long time on Danaher Corp (NYSE:DHR).

In Q3 2020, the number of bullish hedge fund positions on Danaher Corp (NYSE:DHR) stock decreased by about 1% from the previous quarter (see the chart here), so a number of other hedge fund managers believe in Danaher’s growth potential. Our calculations showed that Danaher Corp (NYSE:DHR) isn’t ranked among the 30 most popular stocks among hedge funds.

The top 10 stocks among hedge funds returned 216% since the end of 2014 and outperformed the S&P 500 Index ETFs by more than 121 percentage points. We know it sounds unbelievable. You have been dismissing our articles about top hedge fund stocks mostly because you were fed biased information by other media outlets about hedge funds’ poor performance. You could have doubled the size of your nest egg by investing in the top hedge fund stocks instead of dumb S&P 500 ETFs. Below you can watch our video about the top 5 hedge fund stocks right now. All of these stocks had positive returns in 2020.

Video: Top 5 Stocks Among Hedge Funds

At Insider Monkey we scour multiple sources to uncover the next great investment idea. For example, Federal Reserve has been creating trillions of dollars electronically to keep the interest rates near zero. We believe this will lead to inflation and boost real estate prices. So, we recommended this real estate stock to our monthly premium newsletter subscribers. We go through lists like the 10 most profitable companies in the world to pick the best large-cap stocks to buy. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on our website:

Disclosure: None. This article is originally published at Insider Monkey.